High maternal sodium intake alters sex-specific renal renin-angiotensin system components in newborn Wistar offspring

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
CAMBRIDGE UNIV PRESS
Citação
JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, v.7, n.3, p.282-289, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
This study aimed to evaluate the systemic and renal renin-angiotensin-aldosterone system (RAAS) at birth in male and female offspring and in mothers fed a high sodium diet (HSD) before and during gestation. Female Wistar rats were fed a HSD (8.0% NaCl) or a normal sodium diet (1.3% NaCl) from 8 weeks of age until delivery of their first litter. Maternal body weight, tail blood pressure, and food and water intake were evaluated. The litter sizes were assessed, and the body and kidney weights of the offspring were measured. Both mothers and offspring were euthanized immediately following the birth of the pups to evaluate plasma renin activity (PRA), renal renin content (RRC), renal angiotensin-converting enzyme (ACE) activity, renal angiotensin (Ang) II content, serum aldosterone (ALDO) levels, and renal cortical and medullary renin messenger RNA expression. In mothers in the HSD group, water intake and kidney mass were higher, whereas renal ACE activity, Ang II, PRA, ALDO and RRC were decreased. In the offspring of HSD-fed dams, the body and kidney mass were lower in both genders, renal ACE activity was lower in females and renal Ang II was lower in males. PRA, RRC, renin gene expression and ALDO levels did not differ between the groups of offspring. The data presented herein showed that a maternal HSD during pregnancy induces low birth weight and a sex-specific response in the RAAS in offspring.
Palavras-chave
high sodium diet, newborn, offspring, renin-angiotensin-aldosterone system
Referências
  1. Allard C, 2015, EPIGENETICS-US, V10, P342, DOI 10.1080/15592294.2015.1029700
  2. Balbi APC, 2004, PEDIATR NEPHROL, V19, P1212, DOI 10.1007/s00467-004-1586-x
  3. BARKER DJP, 1989, LANCET, V2, P577
  4. Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424
  5. Bie P, 2009, ACTA PHYSIOL, V195, P187, DOI 10.1111/j.1748-1716.2008.01932.x
  6. Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442
  7. Chen Y, 2004, ACTA PHYSIOL SCAND, V181, P529, DOI 10.1111/j.1365-201X.2004.01327.x
  8. Chevalier RL, 1996, AM J PHYSIOL-REG I, V270, pR393
  9. Cholewa BC, 2005, ACTA PHYSIOL SCAND, V183, P309, DOI 10.1111/j.1365-201X.2004.01401.x
  10. Coelho MS, 2006, NUTR METAB CARDIOVAS, V16, P148, DOI 10.1016/j.numecd.2005.09.001
  11. CONTRERAS RJ, 1989, AM J PHYSIOL, V256, pR70
  12. Contreras RJ, 2000, PHYSIOL BEHAV, V71, P173, DOI 10.1016/S0031-9384(00)00331-0
  13. da Silva AA, 2003, NUTR METAB CARDIOVAS, V13, P133
  14. [Anonymous], 2013, EUR J PHYSL, DOI 10.1007/S00424-012-1171-2
  15. Ding Y, 2010, J HYPERTENS, V28, P1290, DOI 10.1097/HJH.0b013e328337da8f
  16. Drake AJ, 2012, CLIN ENDOCRINOL, V77, P808, DOI 10.1111/j.1365-2265.2012.04453.x
  17. Drenjancevic-Peric I, 2011, KIDNEY BLOOD PRESS R, V34, P1, DOI 10.1159/000320387
  18. Giammattei CE, 1999, AM J PHYSIOL-REG I, V277, pR1230
  19. Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383
  20. Gray C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072682
  21. HALES CN, 1991, BRIT MED J, V303, P1019
  22. HAZON N, 1990, J ENDOCRINOL, V127, P243, DOI 10.1677/joe.0.1270243
  23. He FJ, 2003, J RENIN-ANGIO-ALDO S, V4, P11, DOI 10.3317/jraas.2003.001
  24. Hiejmans B, 2008, P NATL ACAD SCI USA, V105, P17046
  25. JIMENEZ W, 1985, REV ESP FISIOL, V41, P299
  26. KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251
  27. Kantorowick L, 2008, REPROD SCI, V15, P831, DOI 10.1177/1933719108318599
  28. Leandro SM, 2008, PHYSIOL BEHAV, V95, P5
  29. Lima NKC, 2006, AM J MED SCI, V331, P309, DOI 10.1097/00000441-200606000-00003
  30. Lopez JP, 2015, BMC MED, V13, P293
  31. LUMBERS ER, 1995, CLIN EXP PHARMACOL P, V22, P499, DOI 10.1111/j.1440-1681.1995.tb02057.x
  32. Porter JP, 2007, AM J PHYSIOL-REG I, V293, pR334, DOI 10.1152/ajpregu.00887.2006
  33. Ramos DR, 2012, LIFE SCI, V90, P785, DOI 10.1016/j.lfs.2012.04.011
  34. ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81
  35. SANTOS RAS, 1985, HYPERTENSION, V7, P244
  36. Schenk H D, 1995, Anaesthesiol Reanim, V20, P60
  37. Swenson SJ, 2004, AM J PHYSIOL-REG I, V286, pR764, DOI 10.1152/ajpregu.00492.2003
  38. Tarry-Adkins JL, 2014, AM J CLIN NUTR S, V94, p1765S
  39. Thiery JP, 1989, BIOL EXTRACELLULAR M, P181
  40. TUFROMCREDDIE A, 1994, AM J PHYSIOL, V266, pF911
  41. Vaccari B, 2015, J RENIN-ANGIO-ALDO S, V16, P33, DOI 10.1177/1470320313481081
  42. Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR1131, DOI 10.1152/ajpregu.00037.2003
  43. Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005
  44. Yosipiv IV, 1996, HYPERTENSION, V27, P281
  45. YOSIPIV IV, 1994, HYPERTENSION, V23, P369
  46. Zhou D, 2015, J NUTR BIOCHEM, V26, P1, DOI 10.1016/j.jnutbio.2014.06.011